# Idiopathic Hypertrophic Pachymeningitis with Elevated Anti-Thyroglobulin Antibodies—A Case Report

**Authors:** Paweł Pobudejski, Mateusz Toś, Katarzyna Zawiślak-Fornagiel, Joanna Siuda

PMC · DOI: 10.3390/reports9010015 · Reports - Clinical Practice and Surgical Cases · 2025-12-31

## TL;DR

A rare case of idiopathic hypertrophic pachymeningitis showed improvement with steroids and elevated anti-thyroglobulin antibodies, suggesting a possible autoimmune link.

## Contribution

This case highlights the potential role of autoimmunity in idiopathic hypertrophic pachymeningitis, emphasizing the need for autoimmune screening.

## Key findings

- The patient's symptoms improved with corticosteroids despite stable radiologic findings.
- Elevated anti-thyroglobulin antibodies persisted after thyroidectomy, indicating possible autoimmune activity.
- Autoimmune assessment should be considered in idiopathic hypertrophic pachymeningitis work-up.

## Abstract

Background and clinical significance: Idiopathic hypertrophic pachymeningitis (IHPM) is a rare inflammatory disorder characterized by diffuse or focal dural thickening and heterogeneous presentations. We report a corticosteroid-responsive IHPM with elevated anti-thyroglobulin (anti-Tg) antibodies despite oncologic control after thyroidectomy. This case suggests that systematic assessment for autoimmunity should be a standard component of the IHPM work-up. Case presentation: A 77-year-old woman presented with recurrent vertigo, imbalance, and headaches. Brain MRI showed diffuse pachymeningeal thickening with mild heterogeneous enhancement, radiologically stable over >2 years. Extensive evaluation excluded infectious, neoplastic (including paraneoplastic), cerebrospinal fluid hypotension and systemic autoimmune causes; findings did not support IgG4-related disease. Thyroid work-up revealed hypothyroidism with multinodular goiter; total thyroidectomy was performed, and there was no indication for adjuvant radioiodine therapy. Despite oncologic control, anti-Tg antibodies remained markedly elevated, while anti-thyroid peroxidase antibodies (anti-TPO) declined. Symptoms repeatedly improved with oral methylprednisolone and recurred on taper; adverse effects were mild and manageable. The patient remains under clinical and oncologic surveillance with symptom-guided steroid re-challenge. Conclusions: IHPM may exhibit a dissociation between clinical response and radiologic course. Persistently elevated anti-Tg after thyroidectomy can coexist with IHPM and may signal ongoing autoimmunity rather than active cancer.

## Linked entities

- **Chemicals:** methylprednisolone (PubChem CID 6741)
- **Diseases:** idiopathic hypertrophic pachymeningitis (MONDO:0018673), hypothyroidism (MONDO:0005420), multinodular goiter (MONDO:0000334)

## Full-text entities

- **Genes:** TPO (thyroid peroxidase) [NCBI Gene 7173] {aka MSA, TDH2A, TPX}, TG (thyroglobulin) [NCBI Gene 7038] {aka AITD3, TGN}
- **Diseases:** headaches (MESH:D006261), IgG4-related disease (MESH:D000077733), hypothyroidism (MESH:D007037), vertigo (MESH:D014717), multinodular goiter (MESH:C564546), inflammatory disorder (MESH:D007249), IHPM (MESH:D014390), paraneoplastic (MESH:D010257), cancer (MESH:D009369), hypotension (MESH:D007022), dural thickening (MESH:D013585)
- **Chemicals:** steroid (MESH:D013256), methylprednisolone (MESH:D008775), radioiodine (MESH:C000614965)
- **Species:** Homo sapiens (human, species) [taxon 9606]

## Full text

_Full body text omitted from this summary view._ Fetch the complete paper as Markdown: https://tomesphere.com/paper/PMC12821630/full.md

## Figures

4 figures with captions in the complete paper: https://tomesphere.com/paper/PMC12821630/full.md

## References

33 references — full list in the complete paper: https://tomesphere.com/paper/PMC12821630/full.md

---
Source: https://tomesphere.com/paper/PMC12821630